Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NEOTAD is an oral dietary supplement developed by Biomedica Foscama Group, designed to provide antioxidant support and protect cells from oxidative stress. It is formulated as an orosoluble powder containing a combination of Setria® reduced L-glutathione, Vitamin C (L-ascorbic acid), Vitamin E (d,l-alpha-tocopheryl acetate), and Selenium (L-selenomethionine). As a nutraceutical, it is intended to support normal immune system function and is indicated for use when dietary intake of these nutrients is reduced or when physiological requirements increase. It is marketed as a gluten-free, vegetarian-friendly food supplement rather than a therapeutic pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NEOTAD.